Salute e Benessere
IonOpticks partners with Adelis to accelerate global expansion and innovation
The strategic partnership will enable IonOpticks to scale its operations globally, enhancing product development and better positioning the company to serve its growing customer base. Being closer to its customers and collaborators while also ensuring compatibility across major LC-MS platforms is a key priority, allowing researchers worldwide to benefit from IonOpticks' class-leading chromatography. Adelis' extensive experience, industrial advisor network and resources will support IonOpticks in maintaining its position as the provider of the best solutions for LC-MS proteomics research.
IonOpticks also strengthens its board with the appointment of several industry heavyweights, including Dr. Peter Wrighton-Smith as Chairman. With an established career in scaling life sciences companies, Peter is well-positioned to guide IonOpticks through its next phase of growth. Joining founders Xavier Perronnet and Dr. Jarrod Sandow , the board also welcomes industry leaders Mårten Winge, Sibel Arnes , and Rasmus Molander .
Dr. Peter Wrighton-Smith , newly appointed Chairman of IonOpticks, explains.
says Xavier Perronnet, Chief Executive Officer of IonOpticks.
Perronnet continues.
Director Sibel Arnes and Co-managing Partner Rasmus Molander at Adelis note,
IonOpticks' technology was developed at WEHI (Walter and Eliza Hall Institute of Medical Research) and the company was incubated at the institute for two years. says Dr. Anne-Laure Puaux , Head of Business Development at WEHI.
View original content: https://www.prnewswire.co.uk/news-releases/ionopticks-partners-with-adelis-to-accelerate-global-expansion-and-innovation-302242743.html